Groot K - Search Results

1

Somatostatin receptor expression in lung cancer.

O'Byrne KJ, Halmos G, Pinski J, Groot K, Szepeshazi K, Schally AV, Carney DN. O'Byrne KJ, et al. Among authors: groot k. Eur J Cancer. 1994;30A(11):1682-7. doi: 10.1016/0959-8049(94)00351-5. Eur J Cancer. 1994. PMID: 7833144

2

Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.

Pinski J, Schally AV, Halmos G, Szepeshazi K, Groot K, O'Byrne K, Cai RZ. Pinski J, et al. Among authors: groot k. Br J Cancer. 1994 Nov;70(5):886-92. doi: 10.1038/bjc.1994.415. Br J Cancer. 1994. PMID: 7947094 Free PMC article.

3

Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.

Pinski J, Reile H, Halmos G, Groot K, Schally AV. Pinski J, et al. Among authors: groot k. Cancer Res. 1994 Jan 1;54(1):169-74. Cancer Res. 1994. PMID: 7903203

4

Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines.

Yano T, Pinski J, Groot K, Schally AV. Yano T, et al. Among authors: groot k. Cancer Res. 1992 Aug 15;52(16):4545-7. Cancer Res. 1992. PMID: 1643647

5

Inhibitory effects of analogs of luteinizing hormone-releasing hormone and somatostatin on pancreatic cancers in hamsters. Events that accompany tumor regression.

Szende B, Srkalovic G, Schally AV, Lapis K, Groot K. Szende B, et al. Among authors: groot k. Cancer. 1990 May 15;65(10):2279-90. doi: 10.1002/1097-0142(19900515)65:10<2279::aid-cncr2820651020>3.0.co;2-3. Cancer. 1990. PMID: 1971771

6

Somatostatin analog RC-160 inhibits growth of CFPAC-1 human pancreatic cancer cells in vitro and intracellular production of cyclic adenosine monophosphate.

Qin Y, Ertl T, Groot K, Horvath J, Cai RZ, Schally AV. Qin Y, et al. Among authors: groot k. Int J Cancer. 1995 Mar 3;60(5):694-700. doi: 10.1002/ijc.2910600521. Int J Cancer. 1995. PMID: 7860145

7

Inhibitory effects of analogs of luteinizing hormone-releasing hormone on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.

Pinski J, Reile H, Halmos G, Groot K, Schally AV. Pinski J, et al. Among authors: groot k. Int J Cancer. 1994 Oct 1;59(1):51-5. doi: 10.1002/ijc.2910590112. Int J Cancer. 1994. PMID: 7927904

8

Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice.

Radulovic S, Schally AV, Reile H, Halmos G, Szepeshazi K, Groot K, Milovanovic S, Miller G, Yano T. Radulovic S, et al. Among authors: groot k. Acta Oncol. 1994;33(6):693-701. doi: 10.3109/02841869409121784. Acta Oncol. 1994. PMID: 7946450

9

Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.

Pinski J, Schally AV, Halmos G, Szepeshazi K, Groot K. Pinski J, et al. Among authors: groot k. Cancer Res. 1994 Nov 15;54(22):5895-901. Cancer Res. 1994. PMID: 7954420

10

Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and luteinizing hormone-releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human breast cancer xenografts in athymic nude mice.

Yano T, Pinski J, Szepeshazi K, Halmos G, Radulovic S, Groot K, Schally AV. Yano T, et al. Among authors: groot k. Cancer. 1994 Feb 15;73(4):1229-38. doi: 10.1002/1097-0142(19940215)73:4<1229::aid-cncr2820730417>3.0.co;2-1. Cancer. 1994. PMID: 8313327

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

587 results

Search Page

Filters